| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
BCBS
| Professional | $602.67 | $747.00 | $1,543.00 | |
Cigna
| Facility | $414.53 | $414.53 | $414.53 | |
United
| Professional | $87.07 | $87.07 | $207.31 |
Oncology (urothelial cancer), RNA, analysis by real-time RT-PCR of the FGFR3 (fibroblast growth factor receptor 3) gene analysis (ie, p.R248C [c.742C>T], p.S249C [c.746C>G], p.G370C [c.1108G>T], p.Y373C [c.1118A>G], FGFR3-TACC3v1, and FGFR3-TACC3v3) utilizing formalin-fixed paraffin-embedded urothelial cancer tumor tissue, reported as FGFR gene alteration status
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
BCBS
| Professional | $602.67 | $747.00 | $1,543.00 | |
Cigna
| Facility | $414.53 | $414.53 | $414.53 | |
United
| Professional | $87.07 | $87.07 | $207.31 |